A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient
- PMID: 10694889
A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient
Abstract
Purpose: Pseudomonas aeruginosa proteases are thought to be important virulence factors in the pathogenesis of corneal disease. This study examined protease production from two strains of P. aeruginosa responsible for two very distinct clinical diseases: strain Paer1, isolated from a Contact Lens-induced Acute Red Eye (CLARE), and strain KEI 1025, isolated from a corneal ulcer. Strains were compared to a laboratory strain (ATCC 19660) known to produce severe keratitis in experimentally infected mice for protease production and for ocular virulence.
Methods: Protease production was examined with colorimetric assays, gelatin zymography and western blots. Elastase A activity was quantitated with a staphylolytic assay. Ocular virulence was examined using a mouse scratch model of keratitis.
Results: In contrast to strains KEI 1025 or ATCC 19660, Paer1 was unable to produce enzymatically active elastase A, elastase, and protease IV. All three strains produced active alkaline protease. Strains KEI 1025 and ATCC 19660 produced a fulminant keratitis in mice whereas Paer1 produced a mild transient infection. Restoration of elastase activity in Paer1 via genetic complementation did not result in a virulent phenotype. Co-infection of mouse eyes with strains Paer1 and ATCC 19660 resulted in the eventual loss of Paer1 from corneal tissue.
Conclusions: These studies suggest that P. aeruginosa elastase A and/or protease IV, but not alkaline protease or elastase, contribute to the ocular virulence of this organism.
Similar articles
-
An ocular strain of Pseudomonas aeruginosa is inflammatory but not virulent in the scarified mouse model.Exp Eye Res. 1998 Sep;67(3):347-56. doi: 10.1006/exer.1998.0524. Exp Eye Res. 1998. PMID: 9778416
-
Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.Cornea. 2008 Apr;27(3):320-6. doi: 10.1097/ICO.0b013e31815c5a3f. Cornea. 2008. PMID: 18362661
-
Pseudomonas deficient in protease IV has significantly reduced corneal virulence.Invest Ophthalmol Vis Sci. 1997 Jul;38(8):1535-42. Invest Ophthalmol Vis Sci. 1997. PMID: 9224281
-
Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review.Optom Vis Sci. 2007 Apr;84(4):273-8. doi: 10.1097/OPX.0b013e3180439c3e. Optom Vis Sci. 2007. PMID: 17435510 Review.
-
Are inflammatory events a marker for an increased risk of microbial keratitis?Eye Contact Lens. 2007 Nov;33(6 Pt 2):383-7; discussion 399-400. doi: 10.1097/ICL.0b013e318157d86b. Eye Contact Lens. 2007. PMID: 17975427 Review.
Cited by
-
Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa Keratitis.Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5799-5809. doi: 10.1167/iovs.16-20103. Invest Ophthalmol Vis Sci. 2016. PMID: 27792814 Free PMC article.
-
Pseudomonas aeruginosa Keratitis: Protease IV and PASP as Corneal Virulence Mediators.Microorganisms. 2019 Aug 22;7(9):281. doi: 10.3390/microorganisms7090281. Microorganisms. 2019. PMID: 31443433 Free PMC article. Review.
-
Esculentin-1a(1-21)NH2: a frog skin-derived peptide for microbial keratitis.Cell Mol Life Sci. 2015 Feb;72(3):617-627. doi: 10.1007/s00018-014-1694-0. Epub 2014 Aug 3. Cell Mol Life Sci. 2015. PMID: 25086859 Free PMC article.
-
Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis.Infect Immun. 2002 Apr;70(4):2187-97. doi: 10.1128/IAI.70.4.2187-2197.2002. Infect Immun. 2002. PMID: 11895986 Free PMC article.
-
In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid.Antimicrob Agents Chemother. 2007 Nov;51(11):3853-60. doi: 10.1128/AAC.01317-06. Epub 2007 Aug 27. Antimicrob Agents Chemother. 2007. PMID: 17724155 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical